Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALVR | Common Stock | Award | $0 | +30K | +476.19% | $0.00 | 36.3K | May 17, 2021 | Direct | F1 |
transaction | ALVR | Common Stock | Award | $0 | +170K | +468.32% | $0.00 | 206K | May 17, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALVR | Stock Option (Right to Buy) | Award | $0 | +500K | $0.00 | 500K | May 17, 2021 | Common Stock | 500K | $23.74 | Direct | F3 |
Id | Content |
---|---|
F1 | The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on May 17, 2022. |
F2 | The shares reported in this transaction represent RSUs issued under the Plan. 25% of these RSUs shall vest on May 17, 2022, with the remainder vesting in twelve quarterly installmenters thereafter. |
F3 | 25% of this option shall vest and become exercisable on May 17, 2022, with the remainder vesting in twelve quarterly installments thereafter. |